Services
Research
Training
Industry
About us
ChEBI
Examples:
iron*
,
InChI=1S/CH4O/c1-2/h2H,1H3
,
caffeine
Advanced
Home
Advanced Search
Browse
Documentation
Download
Tools
About ChEBI
Submit
Contact us
DiNA
Statistics
Entity of the Month
Periodic Table
Ontology
Train online
User Manual
Annotation Manual
Developer Manual
FAQ's
BiNChE
libChEBI
Web Services
ChEBI
> ChEBI Ontology
CHEBI:35660 - HIV protease inhibitor
Main
ChEBI Ontology
Automatic Xrefs
Reactions
Pathways
Models
ChEBI Name
HIV protease inhibitor
ChEBI ID
CHEBI:35660
Definition
An inhibitor of HIV protease, an enzyme required for production of proteins needed for viral assembly.
Stars
This entity has been manually annotated by the ChEBI Team.
Members of HIV protease inhibitor Class
Download as
Tab-delimited
,
XML
,
SDF
atazanavir
Mass :704.85550
Formula : C38H52N6O7
nelfinavir
Mass :567.78200
Formula : C32H45N3O4S
tipranavir
Mass :602.66400
Formula : C31H33F3N2O5S
darunavir
Mass :547.66400
Formula : C27H37N3O7S
nelfinavir mesylate
Mass :663.88800
Formula : C32H45N3O4S.CH4O3S C33H49N3O7S2
XV638
Mass :758.910
Formula : C41H38N6O5S2
ritonavir
Mass :720.94400
Formula : C37H48N6O5S2
semicochliodinol B
Mass :438.476
Formula : C27H22N2O4
U100313
Mass :558.66460
Formula : C33H38N2O6
colossolactone V
Mass :618.79790
Formula : C35H54O9
colossolactone VII
Mass :558.74590
Formula : C33H50O7
colossolactone VIII
Mass :538.67170
Formula : C32H42O7
2alpha,19alpha-dihydroxy-3-oxo-12-ursen-28-oic acid
Mass :486.68320
Formula : C30H46O5
isovanillin
Mass :152.149
Formula : C8H8O3
schisanlactone A
Mass :464.63620
Formula : C30H40O4
saquinavir
Mass :670.84080
Formula : C38H50N6O5
Paxlovid
Definition : A mixture containing nirmatrelvir and ritonavir. It is co-administered in tablet form for the treatment and post-exposure prophylaxis of COVID-19.
lopinavir
Mass :628.80080
Formula : C37H48N4O5
geumonoid
Mass :486.68320
Formula : C30H46O5
Kaletra
Mass :1349.760
Formula : C37H48N6O5S2.C37H48N4O5
indinavir
Mass :613.78968
Formula : C36H47N5O4
amprenavir
Mass :505.62802
Formula : C25H35N3O6S
carnosic acid
Mass :332.435
Formula : C20H28O4
N-s-butyl-N-[(2R,3S)-3-({[(3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yloxy]carbonyl}amino)-2-hydroxy-4-phenylbutyl]-4-(hydroxymethyl)benzenesulfonamide
Mass :560.70318
Formula : C29H40N2O7S
semicochliodinol A
Mass :438.47460
Formula : C27H22N2O4
longipedumin A
Mass :532.58100
Formula : C31H32O8
epigallocatechin-(4beta->8,2beta->O-7)-epicatechin
Mass :592.50380
Formula : C30H24O13
Graph View
Tree View
CHEBI:50906 role
CHEBI:24432 biological role
CHEBI:35222 inhibitor
CHEBI:23924 enzyme inhibitor
CHEBI:76759 EC 3.* (hydrolase) inhibitor
CHEBI:60258 EC 3.4.* (hydrolases acting on peptide bond) inhibitor
CHEBI:37670 protease inhibitor
CHEBI:35660 HIV protease inhibitor
CHEBI:37924 atazanavir
CHEBI:7496 nelfinavir
CHEBI:63628 tipranavir
CHEBI:367163 darunavir
CHEBI:7497 nelfinavir mesylate
CHEBI:10050 XV638
CHEBI:45409 ritonavir
CHEBI:66462 semicochliodinol B
CHEBI:46238 U100313
CHEBI:65649 colossolactone V
CHEBI:65650 colossolactone VII
CHEBI:65651 colossolactone VIII
CHEBI:65783 2α,19α-dihydroxy-3-oxo-12-ursen-28-oic acid
CHEBI:193161 isovanillin
CHEBI:66431 schisanlactone A
CHEBI:63621 saquinavir
CHEBI:192712 Paxlovid
CHEBI:31781 lopinavir
CHEBI:65959 geumonoid
CHEBI:145924 Kaletra
CHEBI:44032 indinavir
CHEBI:40050 amprenavir
CHEBI:65585 carnosic acid
CHEBI:46414
N
-
s
-butyl-
N
-[(2
R
,3
S
)-3-({[(3a
S
,5
R
,6a
R
)-hexahydro-2
H
-cyclopenta[
b
]furan-5-yloxy]carbonyl}amino)-2-hydroxy-4-phenylbutyl]-4-(hydroxymethyl)benzenesulfonamide
CHEBI:66461 semicochliodinol A
CHEBI:66591 longipedumin A
CHEBI:65854 epigallocatechin-(4β→8,2β→
O
-7)-epicatechin
CHEBI:52206 biochemical role
CHEBI:23924 enzyme inhibitor
CHEBI:76759 EC 3.* (hydrolase) inhibitor
CHEBI:60258 EC 3.4.* (hydrolases acting on peptide bond) inhibitor
CHEBI:37670 protease inhibitor
CHEBI:35660 HIV protease inhibitor
CHEBI:37924 atazanavir
CHEBI:7496 nelfinavir
CHEBI:63628 tipranavir
CHEBI:367163 darunavir
CHEBI:7497 nelfinavir mesylate
CHEBI:10050 XV638
CHEBI:45409 ritonavir
CHEBI:66462 semicochliodinol B
CHEBI:46238 U100313
CHEBI:65649 colossolactone V
CHEBI:65650 colossolactone VII
CHEBI:65651 colossolactone VIII
CHEBI:65783 2α,19α-dihydroxy-3-oxo-12-ursen-28-oic acid
CHEBI:193161 isovanillin
CHEBI:66431 schisanlactone A
CHEBI:63621 saquinavir
CHEBI:192712 Paxlovid
CHEBI:31781 lopinavir
CHEBI:65959 geumonoid
CHEBI:145924 Kaletra
CHEBI:44032 indinavir
CHEBI:40050 amprenavir
CHEBI:65585 carnosic acid
CHEBI:46414
N
-
s
-butyl-
N
-[(2
R
,3
S
)-3-({[(3a
S
,5
R
,6a
R
)-hexahydro-2
H
-cyclopenta[
b
]furan-5-yloxy]carbonyl}amino)-2-hydroxy-4-phenylbutyl]-4-(hydroxymethyl)benzenesulfonamide
CHEBI:66461 semicochliodinol A
CHEBI:66591 longipedumin A
CHEBI:65854 epigallocatechin-(4β→8,2β→
O
-7)-epicatechin
CHEBI:33281 antimicrobial agent
CHEBI:22587 antiviral agent
CHEBI:64946 anti-HIV agent
CHEBI:35660 HIV protease inhibitor
CHEBI:37924 atazanavir
CHEBI:7496 nelfinavir
CHEBI:63628 tipranavir
CHEBI:367163 darunavir
CHEBI:7497 nelfinavir mesylate
CHEBI:10050 XV638
CHEBI:45409 ritonavir
CHEBI:66462 semicochliodinol B
CHEBI:46238 U100313
CHEBI:65649 colossolactone V
CHEBI:65650 colossolactone VII
CHEBI:65651 colossolactone VIII
CHEBI:65783 2α,19α-dihydroxy-3-oxo-12-ursen-28-oic acid
CHEBI:193161 isovanillin
CHEBI:66431 schisanlactone A
CHEBI:63621 saquinavir
CHEBI:192712 Paxlovid
CHEBI:31781 lopinavir
CHEBI:65959 geumonoid
CHEBI:145924 Kaletra
CHEBI:44032 indinavir
CHEBI:40050 amprenavir
CHEBI:65585 carnosic acid
CHEBI:46414
N
-
s
-butyl-
N
-[(2
R
,3
S
)-3-({[(3a
S
,5
R
,6a
R
)-hexahydro-2
H
-cyclopenta[
b
]furan-5-yloxy]carbonyl}amino)-2-hydroxy-4-phenylbutyl]-4-(hydroxymethyl)benzenesulfonamide
CHEBI:66461 semicochliodinol A
CHEBI:66591 longipedumin A
CHEBI:65854 epigallocatechin-(4β→8,2β→
O
-7)-epicatechin
Relationship Types
is a
has part
is conjugate base of
is conjugate acid of
is tautomer of
is enantiomer of
has functional parent
has parent hydride
is substituent group from
has role
Status
Checked
Unchecked